Effect of fibrinolytic therapy on ST-elevation myocardial infarction clinical outcomes during the COVID-19 pandemic: A systematic review and meta-analysis.

Anwar Khedr,Hussam Al Hennawi, Muhammed Khuzzaim Khan, Mostafa Elbanna,Abbas B Jama, Ekaterina Proskuriakova,Hisham Mushtaq,Mikael Mir,Sydney Boike,Ibtisam Rauf,Aalaa Eissa,Meritxell Urtecho,Thoyaja Koritala,Nitesh Jain,Lokesh Goyal,Salim Surani,Syed A Khan

World journal of cardiology（2023）

引用 0|浏览3

暂无评分

摘要

There is an increased incidence of fibrinolysis during the pandemic period, but it has no effect on the risk of all-cause mortality. The low- and middle-income status has a significant impact on the all-cause mortality rate and the incidence of fibrinolysis.

查看译文

关键词

ST-elevation myocardial infarction, Myocardial infarction, Thrombolytic therapy, Fibrinolysis, COVID-19, Pandemics

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要